Valuation: Psychemedics Corporation

Market Cap 9.79M 8.51M 7.92M 7.27M 13.74M 935M 13.95M 93.38M 36.65M 465M 36.77M 35.96M 1.56B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.29M 7.72M 7.09M 13.38M 911M 13.59M 90.99M 35.71M 453M 35.83M 35.04M 1.52B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 day+13.18%
3 months+13.18%
6 months+38.33%
Current year+55.62%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
5.1
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 17/08/2023
Director of Finance/CFO 36 27/11/2023
Corporate Officer/Principal 40 21/09/2023
Director TitleAgeSince
Director/Board Member 64 16/03/2021
Director/Board Member 58 04/04/2022
Director/Board Member 64 12/08/2022
Date Insider Type Main position Quantity % Market Cap.
13/12/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
10/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
10/12/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
+13.18%-.--%+11.41%-49.80% 15.24M
-0.70%+2.20%+100.33%+492.13% 38.35B
-2.01%+4.19%+18.89%+44.53% 25.01B
-2.84%+3.02%-20.83%-37.81% 7.58B
+1.74%+3.59%+16.54%+92.81% 5.02B
+1.41%+8.30%+20.93%+63.80% 3.33B
-5.58%+10.17%-36.14%+778.68% 1.93B
-3.72%+10.08%+215.91%-11.77% 1.96B
+2.28%+6.89%-10.02%-61.44% 1.9B
+11.30%+5.41%+19.44%+6.39% 1.83B
Average +1.51%+5.12%+33.65%+131.75% 8.69B
Weighted average by Cap. -0.90%+3.60%+53.89%+250.21%

Financials

2023 2024
Net sales 22.1M 19.21M 17.88M 16.42M 31M 2.11B 31.48M 211M 82.72M 1.05B 82.99M 81.17M 3.52B 19.68M 17.11M 15.93M 14.62M 27.62M 1.88B 28.04M 188M 73.68M 936M 73.93M 72.3M 3.14B
Net income -4.15M -3.61M -3.36M -3.09M -5.83M -397M -5.92M -39.62M -15.55M -197M -15.6M -15.26M -662M -1.86M -1.62M -1.51M -1.38M -2.61M -178M -2.65M -17.75M -6.97M -88.44M -6.99M -6.84M -297M
Net Debt 334K 290K 270K 248K 469K 31.88M 476K 3.19M 1.25M 15.87M 1.25M 1.23M 53.23M -251K -218K -203K -186K -352K -23.96M -358K -2.39M -940K -11.93M -943K -922K -40M
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PMDI Stock